A data‐driven, multi‐domain brain gray matter signature as a powerful biomarker associated with several clinical outcomes

Abstract INTRODUCTION Characterizing pathological changes in the brain that underlie cognitive impairment, including Alzheimer's disease and related disorders, is central to clinical concerns of prevention, diagnosis, and treatment. METHODS We describe the properties of a brain gray matter regi...

Full description

Saved in:
Bibliographic Details
Main Authors: Evan Fletcher, Brandon Gavett, Sarah Tomaszewski Farias, Keith Widaman, Rachel Whitmer, Audrey P. Fan, Maria Corrada, Charles DeCarli, Dan Mungas
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Online Access:https://doi.org/10.1002/dad2.70026
Tags: Add Tag
No Tags, Be the first to tag this record!